Last reviewed · How we verify
NCT03087188: InhaliPAD
Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet
trial testing Utilization of inhalator in Obstructive Lung Disease in 114 participants. Completed in 15 March 2017.
15 March 2017
Quick facts
| Lead sponsor | RWTH Aachen University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 114 |
| Start date | 9 September 2015 |
| Primary completion | 15 March 2017 |
| Estimated completion | 15 March 2017 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Utilization of inhalator
Conditions studied
- Obstructive Lung Disease — all drugs for Obstructive Lung Disease →
- COPD — all drugs for COPD →
- Asthma — all drugs for Asthma →
Sponsor
RWTH Aachen University
Who can join
18 and older, any sex, with Obstructive Lung Disease or COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are different therapy strategies for patients suffering on obstructive lung disease like chronic obstructive pulmonary disease (COPD), and asthma bronchial available. One of these strategies includes inhalative drugs, e.g. ß2-mimetics, anticholinergic drugs, or glucocorticoids, which are indicated often and which can be used with different inhalation devices. Dry powder inhalators, and dosieraerosol are used the most in clinical routine. Further strategies in treating obstructive lung disease are innovative systems like Respimat or systems with liquid inhalation. However, the success of the therapy depends on the correct application technique. In the clinical routine a high error rate was observed. Consequently, the initiative of the German league of respiratory tracts published internet-based film sequences in order to demonstrate how to use an inhalator correctly. These films are available in the internet for everyone and can be watched as often as needed in order to improve technique and facilitate training. Therefore, in this study we aim to evaluate the following aspects: * amount of wrong applications in ambulant and hospitalized patients (wrong in terms of lack of knowledge on how to use the inhalator or incorrect utilization) * amount of correct applications in patients who had first used the inhalator incorrectly but improved technique by watching the film sequences * evaluation of learning success within 2 weeks to 2 months (follow-up visit in the ambulance)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03087188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Lung Disease
Currently open trials in the same condition.
- NCT02797275 — Secondhand Smoke Respiratory Health Study · Phase 4 · active not recruiting
Other RWTH Aachen University trials
Trials by the same sponsor.
- NCT06390384 — Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric B · NA · not yet recruiting
- NCT07322796 — Smoking Cessation Before Bronchoscopy or CT-guided Puncture · recruiting
- NCT04996914 — Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma · NA · not yet recruiting
- NCT07053956 — Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma · NA · completed
- NCT07140536 — The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Perfo · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03087188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RWTH Aachen University
- Last refreshed: 22 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03087188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing